Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4). (Q43981329)

28 November 2017

title

Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4). (English)

1 reference

28 November 2017

0 references

1 reference

ChEBI release 2020-05-28

W Joseph Thompson

1

1 reference

28 November 2017

Takashi Ashikaga

2

1 reference

28 November 2017

John J Kelly

3

1 reference

28 November 2017

Li Liu

4

1 reference

28 November 2017

Bing Zhu

5

1 reference

28 November 2017

Lakshimi Vemavarapu

6

1 reference

28 November 2017

Samuel J Strada

7

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

28 November 2017

published in

Biochemical Pharmacology

1 reference

28 November 2017

volume

63

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

797-807

1 reference

Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitor

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

TNF modulates endothelial properties by decreasing cAMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Phosphodiesterase inhibitors: new opportunities for the treatment of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Beta-adrenergic modulation of pulmonary transvascular fluid and protein exchange.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Pharmacological modification of pulmonary vascular injury: possible role of cAMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Pulmonary microvascular and macrovascular endothelial cells: differential regulation of Ca2+ and permeability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Ca(2+)-inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Effects of dibutyryl cAMP on pulmonary air embolism-induced lung injury in awake sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Rolipram and Isoproterenol Reverse Platelet Activating Factor-Induced Increases in Pulmonary Microvascular Permeability and Vascular Resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Rolipram inhibits PAF-induced airway microvascular leakage in guinea-pig: a comparison with milrinone and theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Cyclic GMP accumulation in pulmonary microvascular endothelial cells measured by intact cell prelabeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Altered expression of cyclic nucleotide phosphodiesterase isozymes during culture of aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Altered Expression of PDE1 and PDE4 Cyclic Nucleotide Phosphodiesterase Isoforms in 7-oxo-prostacyclin-preconditioned Rat Heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Calcium, calmodulin, and the production of prostacyclin by cultured vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Role of phosphodiesterases in the regulation of endothelial permeability in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900914-5

10.1016/S0006-2952(01)00914-5

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference